Waters Co. (NYSE:WAT) Shares Bought by Swedbank AB

Swedbank AB lifted its position in shares of Waters Co. (NYSE:WAT) by 6.6% in the 3rd quarter, Holdings Channel reports. The fund owned 31,288 shares of the medical instruments supplier’s stock after buying an additional 1,929 shares during the period. Swedbank AB’s holdings in Waters were worth $11,260,000 as of its most recent filing with the SEC.

A number of other large investors have also modified their holdings of the company. OneDigital Investment Advisors LLC grew its position in Waters by 3.8% in the 3rd quarter. OneDigital Investment Advisors LLC now owns 851 shares of the medical instruments supplier’s stock worth $306,000 after purchasing an additional 31 shares during the last quarter. Raymond James Trust N.A. grew its holdings in Waters by 2.4% in the 3rd quarter. Raymond James Trust N.A. now owns 1,340 shares of the medical instruments supplier’s stock worth $482,000 after buying an additional 32 shares in the last quarter. Linscomb Wealth Inc. increased its position in Waters by 0.4% in the 2nd quarter. Linscomb Wealth Inc. now owns 7,841 shares of the medical instruments supplier’s stock valued at $2,275,000 after acquiring an additional 34 shares during the period. Johnson Investment Counsel Inc. raised its stake in Waters by 3.2% during the 2nd quarter. Johnson Investment Counsel Inc. now owns 1,084 shares of the medical instruments supplier’s stock valued at $314,000 after acquiring an additional 34 shares in the last quarter. Finally, Summit Trail Advisors LLC raised its stake in Waters by 3.0% during the 2nd quarter. Summit Trail Advisors LLC now owns 1,170 shares of the medical instruments supplier’s stock valued at $339,000 after acquiring an additional 34 shares in the last quarter. Institutional investors and hedge funds own 94.01% of the company’s stock.

Waters Stock Up 2.6 %

Shares of Waters stock opened at $388.15 on Wednesday. The company has a quick ratio of 1.38, a current ratio of 2.02 and a debt-to-equity ratio of 1.14. Waters Co. has a 12-month low of $273.60 and a 12-month high of $393.38. The firm has a market capitalization of $23.05 billion, a PE ratio of 37.04, a price-to-earnings-growth ratio of 6.83 and a beta of 0.97. The stock’s fifty day moving average is $355.03 and its 200-day moving average is $332.34.

Waters (NYSE:WAT) last posted its quarterly earnings data on Friday, November 1st. The medical instruments supplier reported $2.93 EPS for the quarter, beating analysts’ consensus estimates of $2.68 by $0.25. The company had revenue of $740.30 million during the quarter, compared to analyst estimates of $712.99 million. Waters had a net margin of 21.43% and a return on equity of 49.93%. The business’s quarterly revenue was up 4.0% on a year-over-year basis. During the same period in the prior year, the firm earned $2.84 earnings per share. Equities analysts anticipate that Waters Co. will post 11.79 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the company. Evercore ISI raised their price target on Waters from $335.00 to $355.00 and gave the company an “in-line” rating in a report on Tuesday, October 1st. JPMorgan Chase & Co. boosted their price target on shares of Waters from $340.00 to $380.00 and gave the stock a “neutral” rating in a research report on Monday, November 4th. Deutsche Bank Aktiengesellschaft upped their price target on shares of Waters from $310.00 to $325.00 and gave the stock a “hold” rating in a research note on Monday, November 4th. Cfra set a $389.00 target price on Waters in a report on Thursday, October 17th. Finally, Stifel Nicolaus upped their target price on Waters from $332.00 to $360.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating, three have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $365.85.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.